BiotechTube
Home/Vivace Therapeutics/Andrei W. Konradi, Ph.D.
AW

Andrei W. Konradi, Ph.D.

Head of Chemistry

Vivace Therapeutics

Therapeutic Areas

Oncology

Vivace Therapeutics Pipeline

DrugIndicationPhase
VT3989Refractory pleural and non-pleural mesothelioma; Advanced solid tumors with NF2 mutationsPhase 1/2

Leadership Team at Vivace Therapeutics

SQ
Sofie Qiao, Ph.D.
President and Chief Executive Officer
NS
Neelesh Sharma, M.D., Ph.D.
Chief Medical Officer
TT
Tracy Tang, Ph.D.
VP of Biology / Head of Biology
AP
Amy Pfeiffer, MBA
Head of Operations
View full Vivace Therapeutics profile